Tg(tetO-EGFP/FADD)1Doi
Transgene Detail
|
Symbol: |
Tg(tetO-EGFP/FADD)1Doi |
Name: |
transgene insertion 1, Christophe Benoist |
MGI ID: |
MGI:3574423 |
Transgene: |
Tg(tetO-EGFP/FADD)1Doi Location: unknown
|
Alliance: |
Tg(tetO-EGFP/FADD)1Doi page
|
|
Strain of Origin: |
(C57BL/6 x SJL)F2
|
|
Transgene Type: |
|
Transgenic (Dominant negative, Inducible, Inserted expressed sequence, Reporter) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(tetO-EGFP/FADD)1Doi expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
FADD (8772) |
|
|
|
|
|
Mutation details: The transgene encodes a fusion protein consisting of a truncated, dominant-negative mutant Fas-associated death domain protein in which amino acids 1-79, constituting the death effector domain, have been replaced by the full-length enhanced green fluorescent protein. The coding sequence, preceded by a minimal CMV promoter and a rabbit beta-globin intron and followed by the beta-globin polyadenylation signal, resides downstream of seven copies of the tet operator (tetO). TetO, when present in cells also carrying a tetracycline transactivator (tTA) or reverse transactivator (rtTA) transgene, is inactivated or activated, respectively, by the administration of tetracycline.
(J:94935, J:95005)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:95005 Vence L, et al., DN-FADD and Diabetes. Personal Communication. 1995; |
All: |
2 reference(s) |
|